Skip to main content

Table 5 Effect of Piperonal on Tissue lipid profiles (Liver, Kidney) in normal and experimental obese rats

From: Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats

Groups TC (mg/g tissue) TG (mg/g tissue) Phospholipids (mg/g tissue) Free fatty acids (mg/g tissue)
Liver Kidney Liver Kidney Liver Kidney Liver Kidney
ND control 71.8±5.1 51.9±6.4 105.7±10.5 79.7±7.5 125.2±8.6 71.5±7.2 84.3±5.1 49.4±6.8
HFD control 143.8±16.4 a* 132.1±7.9 a* 218.3±11.1 a* 145.7±8.1a* 203.4±12.7a* 150.9±9.6a* 180.9±6.7a* 119.3±9.4a*
HFD + Orlistat5mg/kg b.wt 76.8±6.5b* 73.5±5.1b* 119.5±13.1b* 87.6±7.4b* 134.8±8.7b* 80.2±6.6b* 87.8±5.1b* 61.2±3.5b*
HFD + Piperonal 20 mg/kg b.wt 129.8±10.6 129.6±6.2 200.1±15.3 136.4±4.5 200.3±15.1 137.9±9.3 148.9±7.1 105.1±5.4
HFD + Piperonal 30 mg/kg b.wt 118.2±16.9 109.6±6.2 182.6±7.4 123.9±7.3 175.1±8.8 123.7±4.3 135.5±11.1 84.9±5.1
HFD + Piperonal 40 mg/kg b.wt 94.6±10.1b* 85.6±5.6b* 142.1±8.1b* 103.1±3.9b* 121.1±10.4b* 88.1±8.3b* 94.8±4.1b* 67.9±5.8b*
  1. Values are statistically significant at *p < 0.05
  2. aSignificantly different from normal control
  3. bSignificantly different from HFD control